Kathleen Ford

Chief Operating Officer

Insider activity · 24 months0 buys6 salesCumulative net flow

Nov 24 · 0 buys · 1 saleDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 1 saleFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 1 saleJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 1 saleFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 2 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (16 ops.)

€1.3M

Latest filing published 29 Sept 2026 for Kura Oncology, Inc., €64k.

Filing timeline

BuySale

Kathleen Ford

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Kathleen Ford: trading record in brief

Kathleen Ford, listed as senior executive, appears in our data through filings on Kura Oncology, Inc. shares, published by SEC (Form 4). The record holds 26 filings, for trades running from 14 September 2020 to 29 September 2026.

Sales make up the whole of the open-market record (16 sales, €1.3M). The rest of the record consists of 4 share grants and 6 option exercises. In 2026 alone, the filings show no purchases and 3 sales.

The newest entry dates from 29 September 2026: an open-market sale of €64k, in Kura Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.